Clinical Trial Update: DTG/3TC vs. BIC/FTC/TAF Maintenance Therapy in People Living With HIV: [Phase 4]

View source ↗

Summary

Phase 4 trial comparing dolutegravir/lamivudine (DTG/3TC) versus bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) as maintenance therapy in people …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BIC/FTC/TAF (bictegravir/emtricitabine/tenofovir alafenamide)
• DTG/3TC (dolutegravir/lamivudine)

Snippet

Sponsor: Fundacion SEIMC-GESIDA | Conditions: HIV-1-infection | Phase 4 | Status: COMPLETED